	Gasdermin-mediated pyroptosis as a prognostic biomarker and therapeutic target in hepatocellular carcinoma. Clin Immunol AlRamadneh TN, Kholmurodov I, Boboyeva N, Hanumanthayya M, Alhady NA, Singhal D, Panigrahi R, Tailor NK. PMID: 42632585 [PubMed - as supplied by publisher]
	Hippo-YAP1 dysregulation as a central driver of therapeutic resistance in cancer: mechanisms and targeting therapeutic strategies. Crit Rev Oncol Hematol Zhao J, Zheng W, Zhang Y, He J, Shan H, Wang B, Guo L, Liang T. PMID: 42632493 [PubMed - as supplied by publisher]
	Tumor's Own Blood Supply: Decoding Vasculogenic Mimicry through Hypoxia, EMT, and Epigenetics. Crit Rev Oncol Hematol Wang Y, Hou Y, Yu Q, Lv S, Li Y, Zhang H, Li W. PMID: 42632491 [PubMed - as supplied by publisher]
	Expanding access to colorectal cancer screening through community pharmacies: Study protocol for the PharmFITâ„¢ randomized controlled trial. Contemp Clin Trials Glascock M, Wangen M, Ferrari RM, O'Leary MC, Schwartz J, Ndugulile M, Unger JM, Li L, Marciniak MW, Reuland DS, Watabayashi K, Brenner AT, Wheeler SB, Shah PD. PMID: 42632449 [PubMed - as supplied by publisher]
	Differential effects of social determinants on cancer survival by age at diagnosis: A population-based study in Alabama. J Geriatr Oncol Fowler ME, Saini G, Baker E, Bhargava M, Aneja R. PMID: 42632370 [PubMed - as supplied by publisher]
	The Brain-tumor axis: Tumor pathogenesis and therapeutic strategies from a cancer neuroscience perspective. Cancer Treat Res Commun Liu Y, Guo C, Wang X, Huang K, Huang S, Cao J, Deng M, Guan T, Zhang Y, Tian S, Zheng Z. PMID: 42632358 [PubMed - as supplied by publisher]
	A retrospective cross-sectional survey of symptoms, comorbidities, return to work, and financial problems experienced by cancer survivors up to 10 years post-diagnosis. Eur J Oncol Nurs Bana M, Betticher D, Denhaerynk K, Küng M. PMID: 42632305 [PubMed - as supplied by publisher]
	Extracellular matrix stiffness and mechanotransduction in cancer drug resistance. Drug Resist Updat Song Y, Huang C, Han J, Wang S, Liu H, Li Y, Jiang Z, Tan X, Wu T, Jiang F. PMID: 42632298 [PubMed - as supplied by publisher]
	Prognostic value of CD103+ tumor-infiltrating lymphocytes in bladder cancer: A systematic review and meta-analysis. Urol Oncol Teixeira EG, Torres LAF, Defante MLR, de Azevedo FM, Souza VC. PMID: 42632294 [PubMed - as supplied by publisher]
	A phase-specific benefit-toxicity framework for perioperative trials in muscle-invasive bladder cancer: A focused review andtrial-level mapping analysis. Urol Oncol Shinohara M, Narita T, Hamaya T, Ichiyama T, Fujita N, Okamoto T, Yamamoto H, Ohyama C, Hatakeyama S. PMID: 42632293 [PubMed - as supplied by publisher]
	miR-638 Upregulation in Serum and Tissues Functions as a Diagnostic and Prognostic Biomarker and Facilitates Prostate Cancer Progression. Urol Oncol Wang L, Yang H, Wang J. PMID: 42632292 [PubMed - as supplied by publisher]
	Integrative single-cell and machine-learning analysis identifies LGALS1 as a macrophage-associated diagnostic and prognostic biomarker in hepatocellular carcinoma. Transl Oncol Wan Y, Huo Q, Yang Y, Xiao Z, Jin J. PMID: 42632122 [PubMed - as supplied by publisher]
	Conversion surgery for advanced biliary tract cancer in the era of molecularly targeted therapy and immunotherapy: from unresectable disease to multidisciplinary curative strategy. Expert Rev Anticancer Ther Okabayashi T, Tabuchi M, Tokumaru T, Uemura S, Tamura S. PMID: 42632073 [PubMed - as supplied by publisher]
	Multifunctional lipid nanocarriers: advancing topical skin cancer treatment. Expert Opin Drug Deliv Vieira Depieri L, Finazzi Morais M, Tiritan LA, Marques Amaral L, da Silva Fernandes LM, Bentley MVLB. PMID: 42632072 [PubMed - as supplied by publisher]
	Precision Pancreatic Cancer Care: From Early Detection to Adaptive Precision Oncology. Cancer Invest Okabayashi T, Tabuchi M, Tokumaru T, Uemura S, Tamura S. PMID: 42632056 [PubMed - as supplied by publisher]
	Neoantigen in cancer immunotherapy: mechanism, therapeutic strategies and future perspectives. Immunotherapy Raj A, Khan Z, Mumtaz, Mehan S, Lamba T, Pandoh N, Dayal K. PMID: 42632040 [PubMed - as supplied by publisher]
	Alcohol amount, drinking patterns, and gastric cancer risk: a nationwide study using targeted maximum likelihood estimation. Eur J Epidemiol Kim CH, Kim B, Lee HA, Choi Y, Kim H, Park B. PMID: 42631910 [PubMed - as supplied by publisher]
	"IL-40: A novel immunoregulatory axis at the crossroads of inflammation, tissue remodeling, and cancer immunity". Immunol Res Ahmadi P, Mozaffari-Jovin S, Faraj TA, Razavi FT, Javanmardi Z, Fadaee A, Doulabi H, Esmaeili SA. PMID: 42631903 [PubMed - indexed for MEDLINE]
	Remodeling the Immune Landscape: How Obesity-Induced SASPs Create a Pro-Tumorigenic Niche. Curr Obes Rep Abd El-Fattah EE, Ngai G, Mooney R, Aboody KS. PMID: 42631902 [PubMed - indexed for MEDLINE]
	Percutaneous Management of Desmoid Tumors. Curr Oncol Rep Landinez GP, Ramasamy SK, Wu X, Naser-Tavakolian K, Sajan A, Siddiqui A, Moody J, Garcia-Reyes K, Raja J, Krishnasamy VP. PMID: 42631901 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 1966006

Page 1 of 98301



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy